APA
Hegde S. S., Pulido-Rios M. T., Luttmann M. A., Foley J. J., Hunsberger G. E., Steinfeld T., Lee T., Ji Y., Mammen M. M. & Jasper J. R. (20181227). Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues. : Pharmacology research & perspectives.
Chicago
Hegde Sharath S, Pulido-Rios M Teresa, Luttmann Mark A, Foley James J, Hunsberger Gerald E, Steinfeld Tod, Lee TaeWeon, Ji Yuhua, Mammen Mathai M and Jasper Jeffrey R. 20181227. Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues. : Pharmacology research & perspectives.
Harvard
Hegde S. S., Pulido-Rios M. T., Luttmann M. A., Foley J. J., Hunsberger G. E., Steinfeld T., Lee T., Ji Y., Mammen M. M. and Jasper J. R. (20181227). Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues. : Pharmacology research & perspectives.
MLA
Hegde Sharath S, Pulido-Rios M Teresa, Luttmann Mark A, Foley James J, Hunsberger Gerald E, Steinfeld Tod, Lee TaeWeon, Ji Yuhua, Mammen Mathai M and Jasper Jeffrey R. Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues. : Pharmacology research & perspectives. 20181227.